Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Psychopharmacology (Berl). 2013 Aug 15;231(1):10.1007/s00213-013-3223-5. doi: 10.1007/s00213-013-3223-5

Table 1.

Efficacy to facilitate ICSS as indicated by maximal drug effects on (a) % Baseline Number of Stimulations per Component, and (b) Y-intercept of rate-dependency plots. The dose producing the maximum effect on each measure is also indicated. Doses are expressed in mg/kg, and data for % Baseline Stimulations and Y-Intercepts are given as mean (95% CL). Values were considered to be significantly different if 95% confidence limits did not overlap.

Drug Dose Maximum % Baseline
Stimulations
Dose Maximum Y-
Intercept
Methcathinone 1.0 192 (147–237) 1.0 0.86 (0.80–0.92)

MDPV 3.2 150 (105–196) 3.2 0.84 (0.82–0.86)

Methylone 10 148 (117–180) 10 0.78 (0.72–0.84)

Mephedrone 3.2 102* (87–118) 10 0.36* (0.30–0.43)
*

Significantly different from methcathinone as indicated by non-overlapping 95% confidence limits.